Genetically engineered cerebral organoids model brain tumor formation.

Area of Science:

• Neuro-oncology
• Cancer Biology
• 3D Organoid Models

Background:

• Brain tumors are highly lethal cancers with limited study models due to genetic heterogeneity.
• Current laboratory models do not fully capture the complexity of brain tumorigenesis.
• Three-dimensional (3D) organoid culture offers a promising avenue for disease modeling.

Purpose of the Study:

• To establish a novel 3D in vitro model for studying brain tumorigenesis.
• To create a neoplastic cerebral organoid (neoCOR) model recapitulating human brain tumor development.
• To investigate the utility of neoCORs in understanding tumor biology and evaluating therapeutic interventions.

Main Methods:

• Development of neoplastic cerebral organoids (neoCORs) using cerebral organoids.
• Introduction of oncogenic mutations via transposon- and CRISPR-Cas9-mediated mutagenesis.
• Screening of clinically relevant mutations from cancer genome projects to define tumorigenic combinations.

Main Results:

• Successfully established neoCORs that recapitulate brain tumorigenesis.
• Defined specific mutation combinations inducing glioblastoma-like and CNS-PNET-like neoplasms.
• Demonstrated neoCOR suitability for studying tumor invasiveness and drug effects linked to DNA aberrations.

Conclusions:

• NeoCORs provide a valuable 3D in vitro model for brain tumor research.
• This model complements existing basic and preclinical models for studying brain tumor biology.
• NeoCORs facilitate investigations into tumor invasiveness and drug screening for specific genetic alterations.